findmyKOL
Clinical trialNCT01781975CompletedPhase 2Interventional

Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus

SponsorUniversity of California, San FranciscoEnrollment67Diabetes Mellitus, Insulin-Dependent, 1Diabetes Mellitus, Type IIDDMInsulin-Dependent Diabetes Mellitus 1Type 1 Diabetes Mellitus
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Walter and Eliza Hall Institute of Medical Research

    Melbourne, Victoria, Australia

United States
  • University of California-San Francisco

    San Francisco, California, United States

  • Barbara Davis Center

    Aurora, Colorado, United States

  • Emory University

    Atlanta, Georgia, United States

  • Indiana University

    Indianapolis, Indiana, United States

  • University of Iowa

    Iowa City, Iowa, United States

  • Joslin Diabetes Center

    Boston, Massachusetts, United States

  • Children'S Hospital of Philadelphia

    Philadelphia, Pennsylvania, United States

  • University of Texas Southwestern

    Dallas, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2014
Primary completion
31 May 2017
Completion
31 May 2018
Last update posted
11 Feb 2020
Registered enrollment
67
Registry id
NCT01781975

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.